1. Home
  2. INAB vs CLEU Comparison

INAB vs CLEU Comparison

Compare INAB & CLEU Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • INAB
  • CLEU
  • Stock Information
  • Founded
  • INAB 2016
  • CLEU 2011
  • Country
  • INAB United States
  • CLEU China
  • Employees
  • INAB N/A
  • CLEU N/A
  • Industry
  • INAB Biotechnology: Pharmaceutical Preparations
  • CLEU Other Consumer Services
  • Sector
  • INAB Health Care
  • CLEU Real Estate
  • Exchange
  • INAB Nasdaq
  • CLEU Nasdaq
  • Market Cap
  • INAB 18.8M
  • CLEU 20.0M
  • IPO Year
  • INAB 2021
  • CLEU 2020
  • Fundamental
  • Price
  • INAB $0.19
  • CLEU $1.94
  • Analyst Decision
  • INAB Strong Buy
  • CLEU
  • Analyst Count
  • INAB 2
  • CLEU 0
  • Target Price
  • INAB $3.60
  • CLEU N/A
  • AVG Volume (30 Days)
  • INAB 786.0K
  • CLEU 64.9K
  • Earning Date
  • INAB 05-08-2025
  • CLEU 01-01-0001
  • Dividend Yield
  • INAB N/A
  • CLEU N/A
  • EPS Growth
  • INAB N/A
  • CLEU N/A
  • EPS
  • INAB N/A
  • CLEU N/A
  • Revenue
  • INAB N/A
  • CLEU $2,413,409.00
  • Revenue This Year
  • INAB N/A
  • CLEU N/A
  • Revenue Next Year
  • INAB N/A
  • CLEU N/A
  • P/E Ratio
  • INAB N/A
  • CLEU N/A
  • Revenue Growth
  • INAB N/A
  • CLEU N/A
  • 52 Week Low
  • INAB $0.13
  • CLEU $0.05
  • 52 Week High
  • INAB $1.74
  • CLEU $7.90
  • Technical
  • Relative Strength Index (RSI)
  • INAB 49.14
  • CLEU 52.88
  • Support Level
  • INAB $0.15
  • CLEU $1.43
  • Resistance Level
  • INAB $0.18
  • CLEU $2.00
  • Average True Range (ATR)
  • INAB 0.02
  • CLEU 0.15
  • MACD
  • INAB 0.01
  • CLEU 0.01
  • Stochastic Oscillator
  • INAB 93.22
  • CLEU 76.32

About INAB IN8bio Inc.

IN8bio Inc is a clinical-stage biopharmaceutical company focused on the discovery, development, and commercialization of gamma-delta T cell product candidates for solid and liquid tumors, by employing allogeneic, autologous, and genetically modified gamma-delta T cells. Its product candidates include INB-400, for the treatment of newly diagnosed glioblastoma, or GBM, INB-100 for the treatment of patients with high-risk leukemias undergoing hematopoietic stem cell transplantation, and other product candidates such as INB-200, INB-300, and INB-500.

About CLEU China Liberal Education Holdings Limited

China Liberal Education Holdings Ltd is an educational service provider operating in China. The company's operating segment includes Sino-foreign Jointly Managed Academic Programs, textbooks and course material sales, Overseas Study Consulting Services, Technological Consulting Services for Smart Campus Solutions and Tailored Job Readiness Training Services. Geographically, it derives revenue from China.

Share on Social Networks: